Litigation

Recent Posts

Johnson & Johnson Reserves $600M To Settle Risperdal, Invega, Natrecor Civil Cases
Posted on 11 Jun 2012 by Tom Moylan

NEW BRUNSWICK, N.J. - (Mealey's) Johnson & Johnson (J&J) expects to incur a special charge against earnings of about $600 million in the second quarter for the potential settlement of civil litigation related to Risperdal, Invega, Natrecor... Read More